IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,616 | -37.5% | 16,400 | -3.3% | 0.00% | – |
Q2 2023 | $119,480 | +16.0% | 16,962 | +0.6% | 0.00% | – |
Q1 2023 | $102,980 | -3.8% | 16,859 | +0.0% | 0.00% | – |
Q4 2022 | $107,000 | -50.0% | 16,856 | -24.5% | 0.00% | – |
Q3 2022 | $214,000 | -12.7% | 22,340 | +0.5% | 0.00% | -100.0% |
Q2 2022 | $245,000 | -36.9% | 22,230 | -4.5% | 0.00% | 0.0% |
Q1 2022 | $388,000 | -16.2% | 23,279 | -4.0% | 0.00% | 0.0% |
Q4 2021 | $463,000 | -26.3% | 24,256 | -4.9% | 0.00% | 0.0% |
Q3 2021 | $628,000 | -4.7% | 25,514 | +0.8% | 0.00% | 0.0% |
Q2 2021 | $659,000 | -15.4% | 25,312 | +2.9% | 0.00% | -50.0% |
Q1 2021 | $779,000 | +46.2% | 24,595 | +114.2% | 0.00% | +100.0% |
Q4 2020 | $533,000 | +40.3% | 11,480 | -1.8% | 0.00% | 0.0% |
Q3 2020 | $380,000 | +21.0% | 11,686 | +2.2% | 0.00% | 0.0% |
Q2 2020 | $314,000 | -5.4% | 11,437 | +3.0% | 0.00% | 0.0% |
Q1 2020 | $332,000 | – | 11,104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |